PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases : A biophysical and nanotoxicological characterization
Carbamazepine (CBZ) is an antiepileptic drug, which also could be used in the treatment of neurodegenerative diseases, such as the Alzheimer's disease. However, its use has been limited due to its low solubility, inefficient pharmacokinetic profiles, and multiple side effects. PAMAM dendrimers,...
Guardado en:
| Autores principales: | Igartúa, Daniela Edith, Martinez, Carolina Soledad, Temprana, Carlos Facundo, Alonso, Silvia del Valle, Prieto, María Jimena |
|---|---|
| Formato: | Articulo Preprint |
| Lenguaje: | Inglés |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/98341 https://ri.conicet.gov.ar/11336/86372 |
| Aporte de: |
Ejemplares similares
-
Combined Therapy for Alzheimer’s Disease : Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity
por: Igartúa, Daniela Edith, et al.
Publicado: (2020) -
Optimization and in vivo toxicity evaluation of G4.5 PAMAM dendrimer-risperidone complexes
por: Prieto, María Jimena, et al.
Publicado: (2014) -
G4.5 Pamam Dendrimer-Risperidone: Biodistribution and Behavioral Changes in In Vivo Model
por: Prieto, María Jimena, et al.
Publicado: (2013) -
Selective cytotoxicity of PAMAM G5 core-PAMAM G2.5 shell tecto-dendrimers on melanoma cells
por: Schilrreff, Priscila, et al.
Publicado: (2012) -
Neurodegenerative Diseases and the Human Microbiota /
por: Carrasco, Luis
Publicado: (2020)